Explore our prototype complexes and therapeutic innovations.
Antibacterial complex with enhanced uptake and membrane disruption activity. Shown to reduce resistance emergence.
Anti-inflammatory scaffold with ROS-responsive redox behavior. Designed for timed release in oxidative environments.
Antiviral MDC prototype enhancing protein binding affinity and oral bioavailability. Targets cytoplasmic viral proteins.
Oncology-targeted agent with pH-activated cytotoxicity. Stable at blood pH, active in acidic tumor microenvironments.
Proposed MDC for viral hepatitis with iron-mediated targeting of hepatic enzymes. Enhances metabolic stability.
Neuroprotective prototype designed for spinal cord injury and CNS repair. Evaluated for axon regeneration pathways.